[at noodls] – FDA acknowledges aplastic anemia as rare disease and requests further data from the company in connection with application HAIFA, ISRAEL, November 21, 2012 — Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Product Candidate Targets Orthopedic and Sports Injuries, Addresses a Multi-Billion Dollar Annual Market HAIFA, ISRAEL, November 14, 2012 — Pluristem Therapeutics, Inc . (NASDAQCM:PSTI; TASE: PLTR), a … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – HAIFA, ISRAEL, November 09, 2012 – Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR), a leading developer of placenta-based cell therapies, offered comments on an article published in Bloomberg on … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Pluristem Achieves Milestone Towards Completion of its New GMP Manufacturing Facility for Commercial Production of PLX Cells , October 23, 2012 – Pluristem Therapeutics, Inc.(NASDAQCM:PSTI; TASE:PLTR), … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Haifa, Israel – September 24, 2012 – Pluristem Therapeutics Inc. (NASDAQCM: PSTI, TASE: PLTR), today announced the closing of the exercise in full of the underwriters’ option to purchase an additional … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboard […]
